LEO Pharma
Sustainability Report and Carbon Intensity Rankings
Is LEO Pharma doing their part?
Their DitchCarbon score is 58
LEO Pharma has a DitchCarbon Score of 58, indicating a moderate level of sustainability in their operations. This score reflects the company’s carbon intensity, which is a measure of how much carbon emissions are produced relative to their activity. A higher score would suggest a lower carbon intensity and a stronger commitment to reducing their environmental impact.
This was calculated based on 30+ company specific emissions data points, the higher the score, the better. Check out our methodology.
Industry emissions intensity
Very low
Low
Medium
High
Very high
LEO Pharma is part of the industrial manufacturing sector, which has a very low carbon intensity ranking compared to other industries. Some industries are more damaging than others, this ranking gives you an indication of how carbon intensive the industry is which this company operates in.
Location emissions intensity
Very low
Low
Medium
High
Very high
LEO Pharma is situated in Denmark, a country with a very low carbon intensity rating. This favorable environmental context supports the company’s sustainability efforts by providing a cleaner energy grid and lower carbon footprint for its operations.
Unlock 30+ emissions data points on LEO Pharma
Get the emissions intelligence you need, no surveys required.
– Historical Scope 1, 2 and 3 emissions
– Coverage of all industries, product level data
– Emissions forecasting, assurances
Unlock 30+ emissions data points on LEO Pharma
Get the emissions intelligence you need, no surveys required.
– Historical Scope 1, 2 and 3 emissions
– Coverage of all industries, product level data
– Emissions forecasting, assurances
16.71%
...this company is doing 16.71% better in emissions than the industry average.
LEO Pharma, founded in 1908 and headquartered in the Shire of Denmark, operates within the industrial manufacturing sector, specifically focusing on dermatological care. As a leader in skin health, the company offers a wide range of products and services to patients in over 100 countries, aiming to improve the quality of life for those with skin conditions. Owned by the LEO Foundation, LEO Pharma employs approximately 5,000 people globally and is committed to advancing dermatology through continuous research and development.
emission intelligence's platform recommendations for LEO Pharma
LEO Pharma should set clear, science-informed targets for reducing their Scope 3 emissions, maintain openness in reporting their progress, and promote environmental responsibility throughout their supply chain to potentially decrease their emissions by 35%.
Good news, LEO Pharma has set SBTi climate action goals
LEO Pharma has committed to significantly reducing their greenhouse gas emissions across company operations, aligning with the ambitious goal of limiting global warming to 1.5°C. This commitment encompasses both direct emissions and indirect emissions from purchased energy.
Participating
Claim this profile
Are you associate with this company?
Help us improve our data and claim this profile.
Our methodology
Read about our emission calculation methodologies, and what the DitchCarbon Score means.
Looking for a specific company?
Search our company directory or contact us for custom data requests.